http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f61e4025981f87232b4dbbe57ddda6c
Outgoing Links
Predicate | Object |
---|---|
family-name | Tan |
name | Min-Han Tan |
given-name | Min-Han |
organization-name | National Cancer Centre, Singapore Authors' Affiliations: 1Genomic Medicine Institute, 2Department of Quantitative Health Sciences, Lerner Research Institute, 3Taussig Cancer Institute; 4Stanley Shalom Zielony Institute of Nursing Excellence, Cleveland Clinic; and 5Department of Genetics, and CASE Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio Affiliations of authors: Department of Medical Oncologyand Cancer Genetics Service, National Cancer Centre Singapore, Singapore (MHT); Institute of Bioengineering and Nanotechnology, Singapore (MHT); Genomic Medicine Institute, Taussig Cancer Institute,Stanley Shalom Zielony Institute of Nursing Excellence, Cleveland Clinic, Cleveland, OH (CE); Department of Genetics and CASE Comprehensive Cancer Daniel Aitor Holdbrook, Malay Singh, Emarene Mationg Kalaw, and Hwee Kuan Lee, Bioinformatics Institute; Malay Singh and Hwee Kuan Lee, National University of Singapore; Yukti Choudhury and Min-Han Tan, Lucence Diagnostics; Yukti Choudhury and Min-Han Tan, Institute of Bioengineering and Nanotechnology; Valerie Koh, Puay Hoon Tan, and John Yuen Shyi Peng, Singapore General Hospital; Hui Shan Tan, Ravindran Kanesvaran, and Min-Han Tan, National Cancer Center Singapore; and Hwee Kuan Lee, Institute for... Institute of Bioengineering and Nanotechnology, 31 Biopolis Way, The Nanos, #07-01, Singapore 138669 Institute of Bioengineering and Nanotechnology, Singapore 138669, Singapore; Lucence Diagnostics Pte Ltd, Singapore 159555, Singapore; Concord Cancer Hospital Singapore, Singapore 289891, Singapore 1Institute of Bioengineering and Nanotechnology Singapore, Singapore.; 6Concord Cancer Hospital Singapore, Singapore.; 7National Cancer Centre Singapore, Singapore. Lucence Diagnostics Pte Ltd, Singapore; Division of Medical Oncology, National Cancer Centre Singapore, Singapore 3Department of Medical Oncology, National Cancer Centre, Singapore.; 4Institute of Bioengineering and Nanotechnology, Singapore.; 5Lucence Diagnostics Pte Ltd, Singapore. Department of Biodevices and Diagnostics, Institute of Bioengineering and Nanotechnology, Singapore, Republic of Singapore Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Republic of Singapore minhan.tan@gmail.com teh.bin.tean@singhealth.com.sg. 6Department of Medical Oncology, National Cancer Centre, Singapore;; 7Department of Molecular Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden; and Department of Medical Oncology, National Cancer Centre Singapore, Republic of Singapore Institute of Bioengineering and Nanotechnology, Singapore 138669; National Cancer Centre Singapore, Singapore 169610 Lucence Health Inc, Palo Alto, CA, USA 1Laboratories of Cancer Genetics,; 12Department of Medicine, Alexandra Hospital, Singapore 5Laboratory of Cancer Genetics and; 12Department of Medical Oncology, National Cancer Center;; 13Department of Medicine, Alexandra Hospital, Singapore, Singapore; National Cancer Centre Singapore, Singapore National Cancer Center, Singapore. Institute of Bioengineering & Nanotechnology, 31 Biopolis Way, The Nanos, Singapore 138669, Singapore 1Laboratory of Cancer Genetics, and; 6Department of Medicine, Alexandra Hospital, Republic of Singapore; and 1Laboratory of Cancer Genetics and Institute of Bioengineering and Nanotechnology, Singapore 138669, Singapore.; National Cancer Centre Singapore, Singapore 169610, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117549, Singapore.; Concord Cancer Hospital, Singapore 289891, Singapore. |
Incoming Links
Total number of triples: 126.